Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Intangibles (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Intangibles for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Intangibles fell 6.04% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 6.04% year-over-year, with the annual reading at $1.1 billion for FY2025, 6.04% down from the prior year.
  • Intangibles hit $1.1 billion in Q4 2025 for Integra Lifesciences Holdings, down from $1.2 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.2 billion in Q2 2024 to a low of $1.0 billion in Q1 2024.
  • Historically, Intangibles has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2021.
  • Biggest five-year swings in Intangibles: grew 18.7% in 2021 and later dropped 8.8% in 2022.
  • Year by year, Intangibles stood at $1.1 billion in 2021, then decreased by 1.66% to $1.1 billion in 2022, then fell by 5.22% to $1.1 billion in 2023, then increased by 13.09% to $1.2 billion in 2024, then fell by 6.04% to $1.1 billion in 2025.
  • Business Quant data shows Intangibles for IART at $1.1 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.